Cancer Research Cancer Epigenetics EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.-G.
Right arrow Articles by Horwitz, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.-G.
Right arrow Articles by Horwitz, S. B.
[Cancer Research 62, 1935-1938, April 1, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Differential Mitotic Responses to Microtubule-stabilizing and -destabilizing Drugs1

Jie-Guang Chen and Susan Band Horwitz2

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461

Although microtubule interacting agents inhibit spindle dynamics, thereby leading to a block in mitosis, we report that low concentrations of these drugs result in differential mitotic effects. Microtubule-stabilizing agents including Taxol, epothilone B, and discodermolide produce aneuploid populations of A549 cells in the absence of a mitotic block. Such aneuploid populations are diminished in an epothilone B-resistant cell line. In contrast, microtubule-destabilizing agents like colchicine, nocodazole, and vinblastine are unable to initiate aneuploidy. The aneuploid cells result from aberrant mitosis as multipolar spindles are induced by the stabilizing drugs, but not by destabilizing agents. The results suggest that the mechanism underlying aberrant mitosis may not be the same as that responsible for mitotic block, and that the former determines the sensitivity of cells to Taxol-like drugs.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Janssen, G. J. P. L. Kops, and R. H. Medema
Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
PNAS, November 10, 2009; 106(45): 19108 - 19113.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
K. E. Gascoigne and S. S. Taylor
How do anti-mitotic drugs kill cancer cells?
J. Cell Sci., August 1, 2009; 122(15): 2579 - 2585.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. E. Bekier, R. Fischbach, J. Lee, and W. R. Taylor
Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit
Mol. Cancer Ther., June 1, 2009; 8(6): 1646 - 1654.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Swanton, B. Nicke, M. Schuett, A. C. Eklund, C. Ng, Q. Li, T. Hardcastle, A. Lee, R. Roy, P. East, et al.
Chromosomal instability determines taxane response
PNAS, May 26, 2009; 106(21): 8671 - 8676.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S.-H. Pan, C.-C. Tai, C.-S. Lin, W.-B. Hsu, S.-F. Chou, C.-C. Lai, J.-Y. Chen, H.-F. Tien, F.-Y. Lee, and W.-B. Wang
Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability
Carcinogenesis, February 1, 2009; 30(2): 366 - 375.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
D. A. Brito, Z. Yang, and C. L. Rieder
Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied
J. Cell Biol., August 25, 2008; 182(4): 623 - 629.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
M. Kwon, S. A. Godinho, N. S. Chandhok, N. J. Ganem, A. Azioune, M. Thery, and D. Pellman
Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes
Genes & Dev., August 15, 2008; 22(16): 2189 - 2203.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. F. Beyer, N. Zhang, R. Hernandez, D. Vitale, J. Lucas, T. Nguyen, C. Discafani, S. Ayral-Kaloustian, and J. J. Gibbons
TTI-237: A Novel Microtubule-Active Compound with In vivo Antitumor Activity
Cancer Res., April 1, 2008; 68(7): 2292 - 2300.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. J. Lee and S. M. Swain
The Epothilones: Translating from the Laboratory to the Clinic
Clin. Cancer Res., March 15, 2008; 14(6): 1618 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. H. Zhuang, Y. E. Hung, L. Hung, R. W. Robey, D. L. Sackett, W. M. Linehan, S. E. Bates, T. Fojo, and M. S. Poruchynsky
Evidence for Microtubule Target Engagement in Tumors of Patients Receiving Ixabepilone
Clin. Cancer Res., December 15, 2007; 13(24): 7480 - 7486.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. P. Gan, E. Pasquier, and M. Kavallaris
Class III {beta}-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non Small Cell Lung Cancer
Cancer Res., October 1, 2007; 67(19): 9356 - 9363.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Rebacz, T. O. Larsen, M. H. Clausen, M. H. Ronnest, H. Loffler, A. D. Ho, and A. Kramer
Identification of Griseofulvin as an Inhibitor of Centrosomal Clustering in a Phenotype-Based Screen
Cancer Res., July 1, 2007; 67(13): 6342 - 6350.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. L. Mooberry, K. N. Weiderhold, S. Dakshanamurthy, E. Hamel, E. J. Banner, A. Kharlamova, J. Hempel, J. T. Gupton, and M. L. Brown
Identification and Characterization of a New Tubulin-Binding Tetrasubstituted Brominated Pyrrole
Mol. Pharmacol., July 1, 2007; 72(1): 132 - 140.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. W. Wilkinson, R. Odedra, S. P. Heaton, S. R. Wedge, N. J. Keen, C. Crafter, J. R. Foster, M. C. Brady, A. Bigley, E. Brown, et al.
AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis
Clin. Cancer Res., June 15, 2007; 13(12): 3682 - 3688.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. Y. Yamada and G. J. Gorbsky
Spindle checkpoint function and cellular sensitivity to antimitotic drugs
Mol. Cancer Ther., December 1, 2006; 5(12): 2963 - 2969.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
G. M. Chin and R. Herbst
Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
Mol. Cancer Ther., October 1, 2006; 5(10): 2580 - 2591.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. S. Huang, L. Lopez-Barcons, B. S. Freeze, A. B. Smith III, G. L. Goldberg, S. B. Horwitz, and H. M. McDaid
Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice
Clin. Cancer Res., January 1, 2006; 12(1): 298 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Pyka, A. Glogowska, H. Dralle, C. Hoang-Vu, and T. Klonisch
Cytoplasmic Domain of proEGF Affects Distribution and Post-Translational Modification of Microtubuli and Increases Microtubule-Associated Proteins 1b and 2 Production in Human Thyroid Carcinoma Cells
Cancer Res., February 15, 2005; 65(4): 1343 - 1351.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. Pourroy, M. Carre, S. Honore, V. Bourgarel-Rey, A. Kruczynski, C. Briand, and D. Braguer
Low Concentrations of Vinflunine Induce Apoptosis in Human SK-N-SH Neuroblastoma Cells through a Postmitotic G1 Arrest and a Mitochondrial Pathway
Mol. Pharmacol., September 1, 2004; 66(3): 580 - 591.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Honore, K. Kamath, D. Braguer, S. B. Horwitz, L. Wilson, C. Briand, and M. A. Jordan
Synergistic Suppression of Microtubule Dynamics by Discodermolide and Paclitaxel in Non-Small Cell Lung Carcinoma Cells
Cancer Res., July 15, 2004; 64(14): 4957 - 4964.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. L. Mooberry, D. A. Randall-Hlubek, R. M. Leal, S. G. Hegde, R. D. Hubbard, L. Zhang, and P. A. Wender
From the Cover: Microtubule-stabilizing agents based on designed laulimalide analogues
PNAS, June 8, 2004; 101(23): 8803 - 8808.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Loegering, S. J. H. Arlander, J. Hackbarth, B. T. Vroman, P. Roos-Mattjus, K. M. Hopkins, H. B. Lieberman, L. M. Karnitz, and S. H. Kaufmann
Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death
J. Biol. Chem., April 30, 2004; 279(18): 18641 - 18647.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. R. Bani, M. I. Nicoletti, N. W. Alkharouf, C. Ghilardi, D. Petersen, E. Erba, E. A. Sausville, E. T. Liu, and R. Giavazzi
Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts
Mol. Cancer Ther., February 1, 2004; 3(2): 111 - 121.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. E. Broker, C. Huisman, S. W. Span, J. A. Rodriguez, F. A. E. Kruyt, and G. Giaccone
Cathepsin B Mediates Caspase-Independent Cell Death Induced by Microtubule Stabilizing Agents in Non-Small Cell Lung Cancer Cells
Cancer Res., January 1, 2004; 64(1): 27 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Honore, K. Kamath, D. Braguer, L. Wilson, C. Briand, and M. A. Jordan
Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation
Mol. Cancer Ther., December 1, 2003; 2(12): 1303 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J.-G. Chen, C.-P. H. Yang, M. Cammer, and S. Band Horwitz
Gene Expression and Mitotic Exit Induced by Microtubule-Stabilizing Drugs
Cancer Res., November 15, 2003; 63(22): 7891 - 7899.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Xiao, J. T. Pinto, J.-W. Soh, A. Deguchi, G. G. Gundersen, A. F. Palazzo, J.-T. Yoon, H. Shirin, and I. B. Weinstein
Induction of Apoptosis by the Garlic-Derived Compound S-Allylmercaptocysteine (SAMC) Is Associated with Microtubule Depolymerization and c-Jun NH2-Terminal Kinase 1 Activation
Cancer Res., October 15, 2003; 63(20): 6825 - 6837.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. L. Tinley, D. A. Randall-Hlubek, R. M. Leal, E. M. Jackson, J. W. Cessac, J. C. Quada Jr., T. K. Hemscheidt, and S. L. Mooberry
Taccalonolides E and A: Plant-derived Steroids with Microtubule-stabilizing Activity
Cancer Res., June 15, 2003; 63(12): 3211 - 3220.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Kelling, K. Sullivan, L. Wilson, and M. A. Jordan
Suppression of Centromere Dynamics by Taxol(R) in Living Osteosarcoma Cells
Cancer Res., June 1, 2003; 63(11): 2794 - 2801.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Asakuma, M. Sumitomo, T. Asano, T. Asano, and M. Hayakawa
Selective Akt Inactivation and Tumor Necrosis Factor-related Apoptosis-inducing Ligand Sensitization of Renal Cancer Cells by Low Concentrations of Paclitaxel
Cancer Res., March 15, 2003; 63(6): 1365 - 1370.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.